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ABSTRACT
Congenital diaphragmatic hernia (CDH) is associated 
with high mortality rates and significant pulmonary 
morbidity, mainly due to disrupted lung development 
related to herniation of abdominal organs into the chest. 
Pulmonary hypertension is a major contributor to both 
mortality and morbidity, however, treatment modalities 
are limited. Novel prenatal and postnatal interventions, 
such as fetal surgery and medical treatments, are 
currently under investigation. Until now, the perinatal 
stabilisation period immediately after birth has been 
relatively overlooked, although optimising support in 
these early stages may be vital in improving outcomes. 
Moreover, physiological parameters obtained from 
the perinatal stabilisation period could serve as early 
predictors of adverse outcomes, thereby facilitating both 
prevention and early treatment of these conditions. 
In this review, we focus on the perinatal stabilisation 
period by discussing the current delivery room guidelines 
in infants born with CDH, the physiological changes 
occurring during the fetal- to- neonatal transition in CDH, 
novel delivery room strategies and early predictors of 
adverse outcomes. The combination of improvements 
in the perinatal stabilisation period and early prediction 
of adverse outcomes may mitigate the need for specific 
postnatal management strategies.
InTRoduCTIon
Congenital diaphragmatic hernia (CDH) is a rare 
birth defect that affects around 1 in 2500 live 
births.1–3 Despite improvements in both prenatal 
and postnatal healthcare this condition is still asso-
ciated with significant neonatal mortality, with rates 
varying between 30% and 50% and the majority of 
deaths occurring in the first year of life.1 3
The diaphragmatic defect can be surgically 
closed after birth, but the degree of disrupted lung 
development aggravated by herniation of abdom-
inal organs into the chest determines survival.4 5 
The resulting pulmonary hypoplasia is character-
ised by abnormal airways and vascular structures 
with increased smooth muscle deposition, leading 
to respiratory insufficiency and cardiovascular 
dysfunction after birth.4 5 The main consequence 
of this cardiovascular dysfunction is pulmonary 
hypertension (PH), which results from underde-
velopment of pulmonary vessels.6 Treating PH in 
CDH infants is challenging and severe PH at the 
age of 1 month is associated with a mortality rate of 
56% at discharge.7 8 The incidence of PH in the first 
week of life was recently reported at almost 70% 
in a cohort of nearly 3500 CDH infants.9 Treating 
PH—or preventing it—is accordingly a major target 
in CDH infants.
In recent decades, researchers have focused on 
developing antenatal interventions aimed at both 
improving pulmonary development by increasing 
the gas exchange area, as well as reducing PH. The 
benefit of temporary tracheal occlusion using fetos-
copy is currently evaluated in a randomised clinical 
trial(Tracheal Occlusion To Accelerate Lung Growth 
trial, NCT00763737/NCT01240057) and the 
results are expected this year. In preclinical research 
antenatal administration of vasodilator drugs, such 
as sildenafil, resulted in improved pulmonary vessel 
development; its efficacy is being investigated in a 
small clinical phase I/IIb trial.10 The efficacy of both 
surfactant and antenatal steroids has been evaluated 
in experimental and clinical trials, but these showed 
conflicting results for both therapies. Indeed, the 
apparent benefit in experimental trials could not 
be replicated in a clinical setting.11–20 Current post-
natal protocols regarding treating PH in CDH are 
mostly based on trials performed in infants with 
persistent PH of the newborn.21 However, infants 
with CDH are often excluded from these studies 
and in fact most of these postnatal strategies do not 
seem effective in treating PH in CDH, emphasising 
the necessity of developing novel approaches.
In this review, we will focus on the perinatal 
stabilisation period in the delivery room. We will 
summarise the available guidelines and discuss the 
known science on how the sequence of physiolog-
ical changes is altered in infants with CDH. In addi-
tion, we will provide an overview of novel delivery 
room strategies that aim to improve short and long- 
term outcomes as well as early predictors of adverse 
outcomes.
delIveRy Room mAnAgemenT: CuRRenT 
guIdelIneS
Current guidelines regarding the resuscitation of 
CDH infants are predominantly opinion based, 
since trials assessing delivery room management are 
lacking. Several large European centres published a 
consensus document, which was updated in 2015 
(CDH EURO Consortium), and a similar guideline 
by the Canadian CDH Collaborative was published 
recently.22 23 In contrast, the American Pediatric 
Surgical Association guideline does not provide 
recommendations regarding delivery room manage-
ment in CDH infants.24
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Figure 1 Cardiopulmonary physiology. (A) Fetal phenotype: left ventricular (LV) preload is mainly derived from umbilical venous blood which 
flows via the ductus venosus and foramen ovale directly into the left atrium. As pulmonary vascular resistance (PVR) is high, pulmonary blood flow 
(PBF) is low and the majority of right ventricular output bypasses the lungs and flows through the ductus arteriosus into the descending aorta. A 
high proportion of cardiac output flows through the low- resistance placental vascular bed, which contributes to a low- systemic vascular resistance 
(afterload). (B) Fetal- to- neonatal transition in healthy infants: umbilical cord clamping decreases LV preload and increases systemic vascular resistance 
by removing both umbilical venous return and the low- resistance placental vascular bed. Lung aeration triggers a decrease in PVR and an increase 
in PBF, which then re- establishes LV preload lost upon cord clamping. The lungs then take over both the cardiovascular and respiratory functions of 
the placenta. (C) Fetal- to- neonatal transition in infants with congenital diaphragmatic hernia: as airway liquid clearance is delayed, the decrease in 
PVR and increase in PBF are also delayed. As such, clamping of the umbilical cord immediately after birth results in a prolonged period of reduced 
cardiac output due to a loss in preload. As cardiac output is critical for defending the infant against hypoxia, a prolonged period of low cardiac output 
combined with limited or no oxygen exchange greatly increases the risk of hypoxic/ischaemic brain injury.
In both the European and Canadian guidelines, the key prin-
ciple of stabilisation is to establish adequate perfusion and oxygen-
ation while avoiding high airway pressures.22 23 Accordingly, 
most infants are intubated immediately after birth. However, in 
cases that are predicted to have good lung development based 
on prenatal assessment, a trial of spontaneous breathing could be 
considered according to the European guideline.22 The necessity 
of immediate support translates into immediate cord clamping 
(ICC) yet both guidelines do not dictate the exact timing of cord 
clamping.22 23 Moreover, for all recommendations the level of 
evidence was graded as very low. This emphasises the necessity 




In the fetal circulation (figure 1A), left ventricular (LV) preload 
is mainly derived from umbilical venous blood flow that is pref-
erentially streamed to the left atrium via the ductus venosus 
and the right- to- left shunt through the foramen ovale.25 26 The 
placental circulation provides oxygenation of fetal blood, and 
greatly reduces overall systemic vascular resistance because 
placental vascular resistance is low.25 26 Pulmonary vascular resis-
tance (PVR) is high since the fetal lungs are not aerated and as a 
result pulmonary blood flow (PBF) is low. Thus, the majority of 
the right ventricular output shunts from right to left through the 
ductus arteriosus to enter the systemic circulation.25
Transition to neonatal phenotype in healthy newborns
At the time of cord clamping several adaptations in the cardio-
vascular and pulmonary system occur as the low resistance 
placental vascular bed is removed from the systemic circulation 
(figure 1B). The loss of umbilical venous return decreases LV 
preload by 30%–50% and, when combined with an instanta-
neous increase in systemic vascular resistance, cord clamping 
results in a decrease in cardiac output as reflected by lower stroke 
volume and heart rate.25 26 This likely explains the observed 
transient bradycardia in the heart rate nomograms of normal 
healthy infants.27 28 Lung aeration triggers the transformation of 
the fetal circulation into the neonatal phenotype by stimulating 
a decrease in PVR and an increase in PBF, which then re- estab-
lishes the preload lost on cord clamping.25 In healthy newborns, 
lung aeration is established rapidly after birth thereby avoiding 
severe hypoxia.5
Transition to neonatal phenotype in CdH
For almost all infants born with CDH, transition to the neonatal 
phenotype is complicated and support from medical profes-
sionals is essential for survival. However, our knowledge of 
how pulmonary hypoplasia affects the cardiopulmonary physi-
ological changes during the transition period is largely based on 
animal models.
Hypoplastic lungs have low compliance, resulting in delayed 
lung aeration after birth (figure 1C).29 In particular, airway 
liquid clearance will be impeded because of an increased resis-
tance to liquid flow down through the airways due to their 
smaller total cross- sectional area, in combination with a reduced 
surface area for liquid movement into the perialveolar tissue.29 
Since lung aeration is the most important trigger for decreasing 
PVR and augmenting PBF, impaired airway liquid clearance and 
thus delayed lung aeration results in a delay in the sequence of 
physiological changes that transform the fetal circulation into a 
neonatal circuit.5 25 30 Accordingly, after cord clamping there is a 
prolonged period of reduced cardiac output, resulting in gradu-
ally worsening of hypoxia and blood pressure fluctuations in the 
pulmonary and systemic vasculature.
Postnatal LV dysfunction—both systolic and diastolic—adds 
to the haemodynamic instability during transition in these CDH 
infants.31 32 The aetiology of LV dysfunction in CDH is multi-
factorial and is related to the relatively small size, resulting from 
both the herniation of abdominal organs as well as the altered LV 
filling haemodynamics.32 33 After cord clamping, LV dysfunction 
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most likely results from reduced LV filling due to the limited 
increase in PBF (eg, preload), LV hypoplasia and acute increase 
in afterload. Moreover, there is transmission of right ventricular 
dysfunction to the LV via ventricular interdependence.31 32
In an ovine diaphragmatic hernia (DH) model, the lambs 
developed respiratory acidosis and poor cerebral oxygenation 
immediately after birth, confirming the hypothesised worsening 
of hypoxia after ICC.30 Hypoxia may result in an enhanced vaso-
constrictive response since the pulmonary vasculature in CDH 
infants is hyper- reactive.30 The resulting increase in vascular 
resistance could worsen PH, ultimately leading to an increase in 
the pre- existing right- to- left shunt, which in turn would aggra-
vate the hypoxia and trigger an ongoing cycle of worsening 
PH.5 8 30 34
delIveRy Room mAnAgemenT: novel ConCepTS
Improving outcomes of infants born with CDH requires clinical 
trials assessing innovative strategies in these infants. Considering 
it is a rare condition, large trials may not always be feasible as 
recruitment is not sufficient to achieve statistical and clinical 
significance within a reasonable time frame. This is also reflected 
by the fact that all concepts described in this paragraph have a 
low grade of recommendation (D). We will discuss early predic-
tors of adverse outcomes and innovative treatment strategies 
during the perinatal stabilisation period that seem promising 
based on preclinical studies.
early prediction of adverse outcomes
Several early prediction models and parameters during the 
immediate postnatal period have been suggested, which could 
allow initiation of prophylactic therapies in an attempt to indi-
vidualise healthcare for each neonate. Herein we will discuss two 
parameters and three prediction models.
Tidal volume
In a prospective study, tidal volume (Vt) of spontaneous breaths 
during stabilisation was associated with mortality, chronic 
lung disease incidence and the need for inhaled nitric oxide.35 
However, Vt was correlated with the observed to expected lung- 
to- head ratio (o/e LHR) and was therefore not considered an 
independent predictor.35 Still, it may be useful in confirming 
disease severity at birth.35
Oxygenation index
The oxygenation index (OI), a value calculated to estimate the 
severity of respiratory failure, may predict mortality in CDH 
infants.36 37 The highest OI recorded in the first 48 hours was 
positively associated with higher mortality, greater length of stay 
and more ventilator days in a retrospective study.37 A subsequent 
retrospective study confirmed that reported mean and best OI 
on day 1 were reliable predictors for mortality.36 Calculating the 
OI requires the arterial PO2 value, which is obtained by means of 
arterial blood gas sampling. However, as most CDH infants have 
a patent ductus arteriosus at this time and preductal PaO2 values 
are thus higher than postductal PaO2 values, the site of blood 
gas sampling could result in a major difference in the calculated 
OI.31 Moreover, arterial blood gas sampling is invasive, requiring 
an arterial line or intermittent arterial puncture.38 The use of 
the oxygenation saturation index, a non- invasive measure, can 
potentially alleviate these disadvantages of OI, although its use 
and usefulness in CDH infants has not been established.38
Score for Neonatal Acute Physiology-II
The Score for Neonatal Acute Physiology- II (SNAP- II Score) 
was first created in 2001 and is calculated with the use of arte-
rial blood pressure, pH, PaO2:FiO2 ratio, body temperature, 
diuresis and seizure activity.39 A prospective trial assessing the 
initial ventilation strategy in CDH infants showed the predic-
tive value of SNAP- II for both mortality as well as the need for 
extracorporeal membrane oxygenation (ECMO).40 The SNAP- II 
Score is easy to use and its potential as early predictor was also 
confirmed in a more recent retrospective study.41
Wilford Hall/Santa Rosa prediction model
The Wilford Hall/Santa Rosa prediction formula was devel-
oped as an easy- to- use clinical method for predicting outcomes 
in the first 24 hours after birth.42 This formula is calculated by 
PaO2[max]−PaCO2[max] and the authors hypothesised that in 
CDH infants with severe PH, arterial PO2 would be less than 
PCO2 as result of compromised gas exchange. However, the 
clinical accuracy of this model was not sufficient in predicting 
outcomes of individual patients, and a subsequent clinical trial 
reported poor discrimination in predicting outcomes as well.42 43
Brindle scoring model
Brindle et al developed a third clinical prediction model in 
2014.44 This model provides a simple and generalisable scoring 
system discriminating between low (<10%), intermediate 
(~20%) and high (~50%) risks of mortality.44 This CDH scoring 
equation includes five predictors: 5 min Apgar, birth weight, PH, 
chromosomal anomalies and major cardiac defects.44 External 
validation has confirmed good performance and discrimination 
among the three groups.45
ex utero intrapartum treatment-to-eCmo procedure
Many of the severely affected CDH infants are treated with 
ECMO, although its efficacy in CDH remains debatable. The 
apparent small gain in survival rates may be offset by increased 
long- term disability in survivors.46 A potential explanation for 
this increased morbidity is that ECMO treatment is usually only 
considered when infants are already critically ill. In an attempt 
to improve the benefits of ECMO, the ex utero intrapartum 
treatment- to- ECMO (EXIT- to- ECMO) procedure was suggested 
for the patients with most severe CDH (<15% predicted lung 
volume).47 48 The first report demonstrated no clear survival 
benefit of EXIT- to- ECMO: mortality was higher than in the non- 
EXIT group.48 On the other hand, there was a higher incidence 
of cardiac anomalies in the EXIT- to- ECMO group.48 A second 
pilot series by the same group evaluated the potential benefit 
on morbidity outcomes.47 While the limited sample size (eight 
EXIT- to- ECMO vs nine non- EXIT) precludes firm conclusions 
from being drawn, there are some indications suggesting that 
survivors of the EXIT- to- ECMO treatment were healthier.47 
The authors, however, conclude that based on their experience, 
which is the largest to date, the use of EXIT- to- ECMO for severe 
CDH infants has not resulted in improved outcomes.47 48
Initial respiratory support
Respiratory support is a major topic in delivery room manage-
ment for CDH infants, however, it is a double- edged sword as 
the importance of ventilator- induced lung injury (VILI) and 
oxygen toxicity is not to be underestimated. ‘Gentle ventilation 
strategies’ and permissive hypercapnia have been implemented 
in delivery room management and on intensive care units, as less 
aggressive ventilator strategies could reduce the risk of VILI and 
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oxygen toxicity.22 However, the optimal way of guiding oxygen 
supplementation in CDH infants is still not clear. The possibility 
of causing inadvertent cerebral hyperoxia was highlighted in a 
recent study using an ovine DH model.5 The authors hypothe-
sised that this occurs when the FiO2 levels are rapidly increased 
in response to reduced SpO2 levels without knowledge of cere-
bral blood flows, leading to a rapid increase in cerebral oxygen 
delivery.5 To directly assess cerebral oxygenation, they have 
speculated that ventilation management may be better guided by 
the use of near- infrared spectroscopy.5
The CDH EURO Consortium also recommends that CDH 
infants may benefit from starting with FiO2 lower than 1.0.
22 
While there is minimal evidence to support this recommendation, 
reduced generation of free radicals associated with lower FiO2 
levels may prevent subsequent pulmonary vasoconstriction.49 In 
a retrospective cohort series that compared starting resuscita-
tion of CDH infants with FiO2 0.5 vs 1.0 (68 vs 45 patients), 
no differences in immediate postnatal outcomes were found.50 
However, infants who required an increase in FiO2 during stabil-
isation were more likely to have an adverse outcome.50
In infants predicted to have mild hypoplasia that are poten-
tially capable of a smooth transition into neonatal life, the initi-
ation of invasive respiratory support may actually cause damage 
to the lungs. To avoid VILI for this specific group—infants with 
a left- sided defect, intra- abdominal liver and o/e LHR ≥50%, a 
trial of spontaneous breathing was postulated in the consensus 
CDH EURO Consortium guideline.51 The benefit of such an 
approach has not been determined objectively, yet this has been 
explored in the Erasmus MC and a manuscript reporting our 
experience over a 5- year period is currently under review.
Timing of cord clamping
The importance of appropriate timing of cord clamping in 
optimising perinatal stabilisation of newborns has been evalu-
ated comprehensively over the last decade.2 52 53 Delayed cord 
clamping (DCC) can be performed using either a ‘time- based’ 
or a ‘physiological- based’ approach, with the latter focusing on 
the infant and its physiological stability rather than a stopwatch. 
Indeed, the high variability between newborns in their needs 
and outcomes already suggests that DCC at an arbitrarily chosen 
point of time may not be sufficient.25 Initially, the benefits of 
DCC were attributed to an increase in placental transfusion, 
reducing the incidence of neonatal anaemia in both term and 
preterm infants. In preterm infants, however, the benefit of DCC 
may be more related to establishing lung aeration prior to cord 
clamping, resulting in a smooth cardiopulmonary adaptation at 
birth.26
In physiological- based cord clamping (PBCC), the umbilical 
cord is clamped after the infant has established lung aeration 
with spontaneous breathing or respiratory support.53 54 Lung 
aeration before cord clamping allows the pulmonary vascula-
ture to dilate and PBF to increase, while maintaining LV preload 
through umbilical venous return.54 55 Thus, an elevated PBF can 
immediately take over the maintenance of LV preload as soon as 
the cord is clamped, allowing the preservation of LV filling and 
function throughout the transitionary period.31 This would lead 
to a better cardiopulmonary transition compared with ICC, with 
prevention of hypoxia and loss of LV output. This concept has 
recently been confirmed in an ovine model, in which cardiopul-
monary transition in DH lambs was compared between ICC and 
PBCC.5 30 In this experiment, PBCC translated into an increase 
in PaO2 and preductal SaO2, an almost 20- fold greater PBF at 
the time of cord clamping (p<0.001), and a significantly lower 
pulmonary artery pressure at 10 min after ventilation onset 
(p<0.001).30 PBCC in patients with CDH could also offer the 
opportunity of commencing resuscitation with 21%–50% instead 
of 100% of oxygen since the infants are still on the placental 
circulation and therefore require less supplemental oxygen.49 56
As mentioned before, due to the hyper- reactive pulmonary 
vasculature in CDH infants temporary PH could lead to a cascade 
ultimately resulting in persistent PH.5 8 30 34 Incorporating PBCC 
into the stabilisation of CDH infants could theoretically reduce 
the risk of ongoing PH in these infants simply by incorporating 
a low- risk intervention. If proven effective in humans, this could 
lead to a significant shift in delivery room strategies. The feasi-
bility of intact cord resuscitation in CDH infants was recently 
demonstrated in two single- centre pilot studies; both studies did 
not observe maternal or neonatal adverse events with DCC.2 57 
These trials were not designed to detect the impact of the inter-
vention on the cardiopulmonary outcomes, although it was 
suggested that DCC improved early cardiorespiratory adapta-
tion at birth.2 However, Foglia et al performed cord clamping 
after colorimetric carbon dioxide detection and as such, it is 
likely that cord clamping was performed without the infants 
being ‘stabilised’.57
Based on the promising preliminary results we will initiate a 
multicentre and international randomised controlled trial evalu-
ating PBCC in CDH infants, the PinC trial (NL69575.078.19), 
starting in 2020. Left- sided CDH infants will be randomised to 
either standard approach (ie, ICC) or PBCC, meaning the umbil-
ical cord will not be clamped until after the infant is stabilised. 
A consistent definition for physiological stability has not been 
established yet, but the goal is to assess adequate lung aeration. 
We decided to use physiological parameters as heart rate and 
oxygenation as proxy for aeration, because of its simplicity and 
is analogous to what is currently used in a trial evaluating the 
outcomes of PBCC in very preterm neonates.58 The PinC trial is 
designed to detect the impact of PBCC on clinical outcomes, for 
example, the occurrence of PH diagnosed in the first 24 hours 
after birth. In parallel, there are other ongoing and anticipated 
initiatives evaluating intact cord resuscitation in CDH infants in 
Denver (CO, USA) and France (nationwide), respectively.
SummARy
Infants with CDH will face important respiratory challenges 
immediately after birth and in some patients, deterioration of 
their clinical situation may be the result of our current manage-
ment strategies at birth. We propose that this earliest time period 
of newborn life has the potential to provide both reliable markers 
for prediction of outcomes, such as PH, and the possibility to 
adopt innovative management strategies in an attempt to have 
more children survive. Optimising perinatal stabilisation could 
protect hypoplastic lungs from damage due to the treatments 
that we employ to save their lives.
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